Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Holmberg

Showing results (111-120 of 287) with videos related to

Pageof 29
Sort By:
BMC Cancer|September 27, 2014
Obesity and cancer: the role of vitamin DThurkaa Shanmugalingam, Danielle Crawley, Cecilia Bosco, et al.
BJU International|April 19, 2017
Association between type 2 diabetes, curative treatment and survival in men with intermediate- and high-risk localized prostate cancerDanielle Crawley, Hans Garmo, Sarah Rudman, et al.
Acta Oncologica (Stockholm, Sweden)|March 24, 2010
Cyclin B is an immunohistochemical proliferation marker which can predict for breast cancer death in low-risk node negative breast cancerAnthoula Koliadi, Cecilia Nilsson, Marit Holmqvist, et al.
International Journal of Cancer|March 10, 2011
Ischemic heart disease and stroke before and during endocrine treatment for prostate cancer in PCBaSe SwedenDavid Robinson, Hans Garmo, Bertil Lindahl, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 8, 2011
Association between levels of C-reactive protein and leukocytes and cancer: three repeated measurements in the Swedish AMORIS studyMieke Van Hemelrijck, Lars Holmberg, Hans Garmo, et al.
BMC Cancer|May 28, 2013
Inorganic phosphate and the risk of cancer in the Swedish AMORIS studyWahyu Wulaningsih, Karl Michaelsson, Hans Garmo, et al.
International Journal of Molecular Epidemiology and Genetics|April 12, 2012
Biomarker-based score to predict mortality in persons aged 50 years and older: a new approach in the Swedish AMORIS studyMieke Van Hemelrijck, Danielle Harari, Hans Garmo, et al.
Scandinavian Journal of Urology|December 18, 2019
Long-term adherence to GnRH agonists in men with prostate cancer. A nation-wide population-based study in prostate cancer data base SwedenGincy George, Hans Garmo, Sarah Rudman, et al.
Breast Cancer Research : BCR|January 24, 2020
Long-term risk of ischemic heart disease after adjuvant radiotherapy in breast cancer: results from a large population-based cohortAnna-Karin Wennstig, Charlotta Wadsten, Hans Garmo, et al.
International Journal of Cancer|February 18, 2010
Breast cancer survival in England, Norway and Sweden: a population-based comparisonHenrik Møller, Fredrik Sandin, Freddie Bray, et al.
Pageof 29

Showing results (111-120 of 287) with videos related to

Sort By:
Pageof 29
BMC Cancer|September 27, 2014
Obesity and cancer: the role of vitamin DThurkaa Shanmugalingam, Danielle Crawley, Cecilia Bosco, et al.
BJU International|April 19, 2017
Association between type 2 diabetes, curative treatment and survival in men with intermediate- and high-risk localized prostate cancerDanielle Crawley, Hans Garmo, Sarah Rudman, et al.
Acta Oncologica (Stockholm, Sweden)|March 24, 2010
Cyclin B is an immunohistochemical proliferation marker which can predict for breast cancer death in low-risk node negative breast cancerAnthoula Koliadi, Cecilia Nilsson, Marit Holmqvist, et al.
International Journal of Cancer|March 10, 2011
Ischemic heart disease and stroke before and during endocrine treatment for prostate cancer in PCBaSe SwedenDavid Robinson, Hans Garmo, Bertil Lindahl, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 8, 2011
Association between levels of C-reactive protein and leukocytes and cancer: three repeated measurements in the Swedish AMORIS studyMieke Van Hemelrijck, Lars Holmberg, Hans Garmo, et al.
BMC Cancer|May 28, 2013
Inorganic phosphate and the risk of cancer in the Swedish AMORIS studyWahyu Wulaningsih, Karl Michaelsson, Hans Garmo, et al.
International Journal of Molecular Epidemiology and Genetics|April 12, 2012
Biomarker-based score to predict mortality in persons aged 50 years and older: a new approach in the Swedish AMORIS studyMieke Van Hemelrijck, Danielle Harari, Hans Garmo, et al.
Scandinavian Journal of Urology|December 18, 2019
Long-term adherence to GnRH agonists in men with prostate cancer. A nation-wide population-based study in prostate cancer data base SwedenGincy George, Hans Garmo, Sarah Rudman, et al.
Breast Cancer Research : BCR|January 24, 2020
Long-term risk of ischemic heart disease after adjuvant radiotherapy in breast cancer: results from a large population-based cohortAnna-Karin Wennstig, Charlotta Wadsten, Hans Garmo, et al.
International Journal of Cancer|February 18, 2010
Breast cancer survival in England, Norway and Sweden: a population-based comparisonHenrik Møller, Fredrik Sandin, Freddie Bray, et al.
Pageof 29